MATW vs. IOVA
Compare and contrast key facts about Matthews International Corporation (MATW) and Iovance Biotherapeutics, Inc. (IOVA).
Performance
MATW vs. IOVA - Performance Comparison
Loading graphics...
MATW vs. IOVA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
MATW Matthews International Corporation | -0.21% | -1.50% | -21.25% | 23.36% | -14.50% | 27.72% | -20.49% | -3.95% | -21.88% | -30.53% |
IOVA Iovance Biotherapeutics, Inc. | 28.57% | -63.11% | -8.98% | 27.23% | -66.53% | -58.86% | 67.63% | 212.77% | 10.62% | 15.11% |
Fundamentals
MATW:
$812.40M
IOVA:
$1.43B
MATW:
$0.72
IOVA:
-$1.06
MATW:
0.58
IOVA:
4.91
MATW:
1.50
IOVA:
2.04
MATW:
$1.38B
IOVA:
$263.50M
MATW:
$469.95M
IOVA:
$256.22M
MATW:
$227.64M
IOVA:
-$357.11M
Returns By Period
In the year-to-date period, MATW achieves a -0.21% return, which is significantly lower than IOVA's 28.57% return. Over the past 10 years, MATW has underperformed IOVA with an annualized return of -4.35%, while IOVA has yielded a comparatively higher -3.87% annualized return.
MATW
- 1D
- 2.58%
- 1M
- -2.31%
- YTD
- -0.21%
- 6M
- 8.48%
- 1Y
- 21.18%
- 3Y*
- -7.12%
- 5Y*
- -5.83%
- 10Y*
- -4.35%
IOVA
- 1D
- 5.72%
- 1M
- -9.07%
- YTD
- 28.57%
- 6M
- 61.75%
- 1Y
- 5.41%
- 3Y*
- -16.87%
- 5Y*
- -35.81%
- 10Y*
- -3.87%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MATW vs. IOVA — Risk / Return Rank
MATW
IOVA
MATW vs. IOVA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Matthews International Corporation (MATW) and Iovance Biotherapeutics, Inc. (IOVA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| MATW | IOVA | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.56 | 0.05 | +0.51 |
Sortino ratioReturn per unit of downside risk | 1.06 | 0.95 | +0.11 |
Omega ratioGain probability vs. loss probability | 1.12 | 1.13 | 0.00 |
Calmar ratioReturn relative to maximum drawdown | 1.22 | -0.03 | +1.24 |
Martin ratioReturn relative to average drawdown | 2.66 | -0.04 | +2.70 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| MATW | IOVA | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.56 | 0.05 | +0.51 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.16 | -0.40 | +0.23 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.12 | -0.05 | -0.07 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.22 | -0.14 | +0.36 |
Correlation
The correlation between MATW and IOVA is 0.17, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
MATW vs. IOVA - Dividend Comparison
MATW's dividend yield for the trailing twelve months is around 3.91%, while IOVA has not paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MATW Matthews International Corporation | 3.91% | 3.85% | 4.37% | 2.54% | 2.92% | 2.36% | 2.87% | 2.12% | 1.90% | 1.33% | 0.81% | 1.01% |
IOVA Iovance Biotherapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
MATW vs. IOVA - Drawdown Comparison
The maximum MATW drawdown since its inception was -75.27%, smaller than the maximum IOVA drawdown of -99.37%. Use the drawdown chart below to compare losses from any high point for MATW and IOVA.
Loading graphics...
Drawdown Indicators
| MATW | IOVA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -75.27% | -99.37% | +24.10% |
Max Drawdown (1Y)Largest decline over 1 year | -16.18% | -54.41% | +38.23% |
Max Drawdown (5Y)Largest decline over 5 years | -58.68% | -94.98% | +36.30% |
Max Drawdown (10Y)Largest decline over 10 years | -75.27% | -96.84% | +21.57% |
Current DrawdownCurrent decline from peak | -56.84% | -97.79% | +40.95% |
Average DrawdownAverage peak-to-trough decline | -24.53% | -84.00% | +59.47% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.38% | 37.72% | -30.34% |
Volatility
MATW vs. IOVA - Volatility Comparison
The current volatility for Matthews International Corporation (MATW) is 7.71%, while Iovance Biotherapeutics, Inc. (IOVA) has a volatility of 30.93%. This indicates that MATW experiences smaller price fluctuations and is considered to be less risky than IOVA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| MATW | IOVA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.71% | 30.93% | -23.22% |
Volatility (6M)Calculated over the trailing 6-month period | 22.59% | 65.62% | -43.03% |
Volatility (1Y)Calculated over the trailing 1-year period | 37.79% | 112.34% | -74.55% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 36.24% | 90.77% | -54.53% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 36.86% | 81.92% | -45.06% |
Financials
MATW vs. IOVA - Financials Comparison
This section allows you to compare key financial metrics between Matthews International Corporation and Iovance Biotherapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities